Science Resources RSS Feeds
|
 |
 |
 |
Postmenopausal Hormone Therapy Current Events | Postmenopausal Hormone Therapy News
|
| Page
1 of
58 |
1148 Results |
|
|
|
Sort By:
Page Views | Date |
Blood cholesterol levels predict risk of heart disease due to hormone therapy
A new analysis of a subgroup of participants in the Women's Health Initiative (WHI) hormone therapy clinical trials suggests that healthy, postmenopausal women whose blood cholesterol levels are normal or lower are not at increased, short-term risk for heart attack when taking hormone therapy. view more (2008-05-27)
ESC Congress 2003: Prothrombotic mutations are associated with increased cardiovascular events in postmenopausal women receiving hormone replacement therapy
IMPORTANT: This press release accompanies a poster or oral session given at the ESC Congress 2003. Written by the investigator himself/herself, this press release does not necessarily reflect the opinion of the European Society of Cardiology Recent studies have suggested that hormone replacement therapy may be associated with an increased... view more... (2003-09-01)
Drop in breast cancer incidence linked to hormone use, not mammograms
A recent decline in breast cancer incidence is unlikely to be caused by a decrease in mammography screening. view more (2007-08-15)
Study shows hormone replacement therapy decreases mortality in younger postmenopausal woman
Hormone replacement therapy (HRT) to treat menopausal estrogen deficiency has been in widespread use for over 60 years. Several observational studies over the years showed that HRT use by younger postmenopausal women was associated with a significant reduction in total mortality; available evidence supported the routine use of HRT to increase... view more... (2009-10-29)
Higher risks for women with diabetes using HRT
Women with diabetes who use hormone replacement therapy are at an increased risk of death from all causes and heart disease, finds a study in this week’s BMJ. view more (2003-02-19)
Scientists uncover new key to the puzzle of hormone therapy and breast cancer
The use of postmenopausal hormone therapy has decreased over time in the United States, which researchers suggest may play a key role in the declining rate of atypical ductal hyperplasia, a known risk factor for breast cancer. view more (2009-11-09)
Further Evidence That Hrt Does Not Protect Against Cardiovascular Disease (p 2001)
Results of a UK randomised trial published in this week's issue of THE LANCET provides further evidence that hormone replacement therapy (HRT) does not offer women protection against cardiovascular disease. Previous observational studies have suggested that HRT could reduce the risk of coronary heart disease (CHD), but results of randomised trials... view more... (2002-12-18)
HRT may prevent endometrial cancer
The long-term use of hormone replacement therapy (HRT) does not increase the risk of endometrial cancer and may even protect the endometrium (the lining of the uterus) from the disease, concludes a study in this week's BMJ. In one of the largest long-term studies of its kind researchers from across the UK collected data from 534 postmenopausal... view more... (2002-07-31)
Early Promise Of Alternative Hormone Treatment For Breast Cancer
A fast-track study in this week's issue of THE LANCET suggests that the drug anastrozole could be an effective option for the treatment of postmenopausal women with hormone-sensitive early breast cancer. Tamoxifen therapy for five years after surgery is the established treatment for postmenopausal women with hormone-sensitive breast cancer.... view more... (2002-06-19)
Fewer wrinkles and firmer skin linked to earlier use of estrogen therapy
Long-term hormone estrogen therapy used earlier in menopause is associated with fewer wrinkles and less skin rigidity in postmenopausal women, Yale School of Medicine researchers report in the August issue of Fertility and Sterility. view more (2005-08-29)
Long-term estrogen therapy linked to breast cancer risk
Long-term estrogen therapy may be related to a higher risk of breast cancer among postmenopausal women who have had a hysterectomy, according to an article in the May 8 issue of Archives of Internal Medicine, one of the JAMA/Archives journals. view more (2006-05-09)
Hormone use related to lower risk of macular degeneration in postmenopausal women
Women who take postmenopausal hormones appear to have a lower risk of developing advanced stages of the eye disease age-related macular degeneration, especially if they had also taken oral contraceptives in the past, according to a report in the April issue of Archives of Ophthalmology, one of the JAMA/Archives journals. view more (2008-04-15)
HRT-breast cancer risk stays same, regardless of family history
The risk of developing breast cancer due to taking hormone replacement therapy appears to be the same for women with a family history of the disease and without a family history. view more (2009-05-20)
Estrogen plus testosterone therapy may increase risk of breast cancer in postmenopausal women
Women who take a combination of estrogen and testosterone to treat the symptoms of menopause may have an increased risk of breast cancer. view more (2006-07-25)
Hormone replacement therapy may improve trip down memory lane
Many women experience declines in their memory during and after menopause, a change thought to be due, in part, to the rapid hormonal changes they weather during that time. view more (2006-11-17)
Timing of start of hormone therapy may have effect on risk of coronary heart disease
Women who initiate hormone therapy closer to menopause tend to have a reduced risk of coronary heart disease compared to women who begin treatment further from menopause. view more (2007-04-04)
Estrogen therapy does not appear to protect postmenopausal women from heart disease
Estrogen therapy does not appear to reduce the risk of heart attack or coronary death in healthy postmenopausal women, although some data suggest a lower coronary heart disease risk in women aged 50 to 59 years. view more (2006-02-14)
Decrease in breast cancer incidence linked to drop in hormone replacement
A special report in the April 19, 2007 edition of The New England Journal of Medicine concludes that the sharp decline in breast-cancer incidence in 2003, followed by a relative stabilization at a lower rater in 2004, is most likely related to the first report of the Women's Health Initiative (WHI) and the ensuing drop in hormone-replacement... view more... (2007-04-19)
Combined HRT increases risk of lobular breast cancer fourfold after just 3 years of use
Postmenopausal women who take combined estrogen/progestin hormone-replacement therapy for three years or more face a fourfold increased risk of developing various forms of lobular breast cancer, according to new findings by researchers at Fred Hutchinson Cancer Research Center. view more (2008-01-15)
New study suggests Rx estrogen delivery through the skin may show safety benefits as opposed to oral delivery
Transdermal delivery of estrogen therapy available by prescription "seems not to alter" the risk of venous thromboembolism (VTE), or blood clotting, in postmenopausal patients when compared to oral delivery, a new study suggests. view more (2009-03-27)
|
|
| Page
1 of
58 |
1148 Results |
|
|
|
Sort By:
Page Views | Date |
|
|
